chimeric antigen receptor t cells, eps8 or wt1 peptide specific dendritic cell
Vaccineexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 23, 2017 (NCT03291444)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Tumor antigensImmunity, active
Tumor antigens immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03291444 | Phase 1 | Sep 23, 2017 | Shenzhen Geno-Immune Medical Institute, Southern Medical University, Sun Yat-Sen University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Shenzhen Geno-Immune Medical Institute | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Southern Medical University | Academic/Hospital | 1 | 1 | 1 | 2017 |
| Sun Yat-Sen University | Academic/Hospital | 1 | 0 | 1 | 2017 |
3 organizations
Page 1 / 1